1. Unraveling the prognostic heterogeneity in patients with advanced melanoma between Australia (OZ) and the United States (US): preliminary report of the PHAMOUS study;Aitkens;J. Clin. Oncol.,2010
2. BRAF and NRAS mutations are frequent in nodular melanoma but are not associated with tumor cell proliferation or patient survival;Akslen;J. Invest. Dermatol.,2005
3. A phase II study of imatinib mesylate (IM) for patients with advanced melanoma harboring somatic alterations of KIT;Carvajal;J. Clin. Oncol.,2009
4. COSMIC database 2010 Catalogue of somatic mutations in cancer http://www.sanger.ac.uk/genetics/CGP/cosmic/
5. Systemic treatments for metastatic cutaneous melanoma;Crosby;Cochrane Database Syst. Rev.,2000